Background and objective Lowering BP to normal levels without quality of life deterioration
is the most important means of reducing cardiovascular risk. Recent studies have …

Nebivolol is a highly selective β 1-adrenoreceptor-blocking agent with a peculiar
pharmacodynamic profile. It has peripheral acute vasodilating properties that are mediated …

Nebivolol is a third generation beta-blocker, which can be distinguished from other beta-
blockers by its hemodynamic profile. It combines beta-adrenergic blocking activity with a …

Objective: Nebivolol is a selective β 1-adrenergic receptor blocker possessing an ancillary
vasodilating effect. The objective of the present study was to study the haemodynamic and …

Nebivolol is a highly selective β 1-adrenergic receptor antagonist with a pharmacologic
profile that differs from those of other drugs in its class. In addition to cardioselectivity …

Nitric oxide (NO) exerts a plethora of vascular beneficial effects. The NO-releasing β-blocker
nebivolol is a racemic mixture of d/l-enantiomers that displays negative inotropic as well as …

The purpose of this study was to establish the antihypertensive efficacy and safety of
nebivolol-a novel, highly selective β 1 blocker with nitric-oxide mediated vasodilatory effects …

We investigated the ability of the angiotensin converting enzyme (ACE) inhibitor imidapril
hydrochloride, and of the calcium channel blocker amlodipine besilate, to prevent …

This study aims to decipher the potential effects of nebivolol in prevention and/or regression
of renal artery dysfunction in diabetes associated with hypertension. Renal arteries were …

The third generation β-blockers possess important ancillary properties besides inhibiting β-
adrenoceptors. Among them, nebivolol activates nitric oxide synthase (NOS). Nebivolol and …